Jinwon Jung

Jinwon Jung serves as the Team Lead of Protein Engineering Team at ABL Bio, where he is responsible for the discovery and development of ADC (Antibody-Drug Conjugate) therapeutics. After receiving his Ph. D. degree in structural biology research using NMR in the Department of Biochemistry at Yonsei University, he conducted structural biology research on HIV at the University of Pittsburgh. He performed research on bispecific antibodies and ADC platform development at Hanwha Chemical Bio R&D Center, and since 2016, as a founding member of ABL Bio, continues to pursue antibody drug research.